KG Pharma ApS

CVR 44911469 · Private limited company (ApS) · Active · Medium risk

KG Pharma ApS is a Private limited company (ApS), founded on , based in Havdrup. The company is registered in the industry installation af isolering. Our model estimates a bankruptcy risk of 2.3% over the next 12 months, which is 1.6 times the average for Danish companies. 1 annual report has been published. The latest annual report (30 Jun 2025) shows equity of DKK 22k and a net result of DKK -18k. CEO: Nicolai Rømer Wiksten.

Bankruptcy risk for KG Pharma ApS

2.3%
probability of bankruptcy within 12 months
Medium risk

1.6 × the average (1.41%) · higher risk than 84% of active Danish companies

Lowest riskHighest risk

Increases the risk

Age (years)2 yrs · bankruptcy rate 18.9%2.1×
Published annual reports1 · bankruptcy rate 18.7%2.1×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×

Reduces the risk

Auditor's statementExtended review · bankruptcy rate 2.9%0.33×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
Equity ratio40%–60% · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
44911469
Status
Active
Company type
Private limited company (ApS)
Founded
(2 years)
Address
Kildebrogårdsvej 11A
4622 Havdrup
Municipality
Solrød
Industry
Installation af isolering (432300)
Bankruptcies in the industry: Tømrer- og bygningssnedkervirksomhed
Share capital
DKK 40k
Auditor
Grant Thornton, Godkendt Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 1
Missing annual reportNo
Negative equityNo
Equity ratio59.2%
Current ratio245%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address18
Going-concern uncertaintyNo

Financials and key figures

Financial year2025
Gross profitDKK -23k
Net profitDKK -18k
EquityDKK 22k
Total assetsDKK 37k
CashDKK 32k
Short-term debtDKK 15k
Avg. employees1

Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Grant Thornton, Godkendt Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
18 Jun 2024 – 30 Jun 2025163

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEONicolai Rømer WikstenCurrent
Owner (100%)KlimaGruppen ApSCurrent
AuditorGrant Thornton, Godkendt RevisionspartnerselskabCurrent
FounderKlimaGruppen ApSCurrent

The CEOs' other companies

Nicolai Rømer Wiksten – 2 other companies

Address history (0 moves)

Kildebrogårdsvej 11A, 4622 Havdrup

Other companies at the same address

Similar companies in Solrød

Questions and answers about KG Pharma ApS

Has KG Pharma ApS gone bankrupt?

No, KG Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of KG Pharma ApS?

Our model estimates a bankruptcy risk of 2.3% over the next 12 months (medium risk), which is 1.6 times the average for Danish companies.

Who is the CEO of KG Pharma ApS?

Nicolai Rømer Wiksten is the CEO of KG Pharma ApS.

Who is the auditor of KG Pharma ApS?

KG Pharma ApS most recently used Grant Thornton, Godkendt Revisionspartnerselskab.

When was KG Pharma ApS founded?

KG Pharma ApS was founded on 18 June 2024.

What is the equity of KG Pharma ApS?

Equity was DKK 22k according to the annual report for the period ending 30 June 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.